These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8639932)

  • 1. High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement.
    Moreau P; Milpied N; de Faucal P; Petit T; Herbouiller P; Bataille R; Harousseau JL
    Blood; 1996 Apr; 87(7):3063-4. PubMed ID: 8639932
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose melphalan followed by autologous stem cell support in primary systemic AL amyloidosis with multiple organ involvement.
    Shimojima Y; Matsuda M; Ishii W; Koyama J; Yamamoto K; Shimodaira S; Sakashita K; Koike K; Ikeda S
    Intern Med; 2005 May; 44(5):484-9. PubMed ID: 15942100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators.
    Phull P; Sanchorawala V; Brauneis D; Sloan JM; Siddiqi OK; Quillen K; Sarosiek S
    Bone Marrow Transplant; 2019 Aug; 54(8):1304-1309. PubMed ID: 30664726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.
    Sanchorawala V
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1131-44. PubMed ID: 25459183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.
    Comenzo RL; Vosburgh E; Falk RH; Sanchorawala V; Reisinger J; Dubrey S; Dember LM; Berk JL; Akpek G; LaValley M; O'hara C; Arkin CF; Wright DG; Skinner M
    Blood; 1998 May; 91(10):3662-70. PubMed ID: 9573002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy options in systemic AL-amyloidosis with renal involvement].
    Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AL amyloidosis, a curable disease?
    Seldin DC
    Amyloid; 2002 Sep; 9(3):203-6. PubMed ID: 12408686
    [No Abstract]   [Full Text] [Related]  

  • 8. Penile ulcers complicating systemic AL amyloidosis: a case report.
    Arun M; Sloan SB; Shelton A; Sanchorawala V
    Amyloid; 2016 Sep; 23(3):203-204. PubMed ID: 27187183
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.
    Vesole DH; Pérez WS; Akasheh M; Boudreau C; Reece DE; Bredeson CN;
    Mayo Clin Proc; 2006 Jul; 81(7):880-8. PubMed ID: 16835967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment of AL amyloidosis].
    Kovacsovics T
    Rev Med Suisse Romande; 2000 Oct; 120(10):771-5. PubMed ID: 11109905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AL amyloidosis manifesting as systemic lymphadenopathy.
    Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.
    Moreau P; Leblond V; Bourquelot P; Facon T; Huynh A; Caillot D; Hermine O; Attal M; Hamidou M; Nedellec G; Ferrant A; Audhuy B; Bataille R; Milpied N; Harousseau JL
    Br J Haematol; 1998 Jun; 101(4):766-9. PubMed ID: 9674753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of AL amyloidosis, current data].
    Jaccard A
    Rev Med Interne; 2006 Nov; 27(11):809-12. PubMed ID: 16934914
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis.
    Freeman B; Brauneis D; Seldin DC; Quillen K; Sloan JM; Renteria AS; Shelton AC; Teschner T; Finn KT; Sanchorawala V
    Bone Marrow Transplant; 2014 Oct; 49(10):1345-6. PubMed ID: 24955784
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis.
    Palladini G; Russo P; Nuvolone M; Lavatelli F; Perfetti V; Obici L; Merlini G
    Blood; 2007 Jul; 110(2):787-8. PubMed ID: 17606766
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation.
    Cowan AJ; Klippel ZK; Stevenson PA; Hyun TS; Tuazon S; Becker PS; Green DJ; Holmberg LA; Coffey DG; Gopal AK; Libby EN
    Amyloid; 2016 Dec; 23(4):254-259. PubMed ID: 27879147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.
    Matsuda M; Yamada T; Gono T; Shimojima Y; Ishii W; Fushimi T; Sakashita K; Koike K; Ikeda S
    Intern Med; 2005 May; 44(5):428-33. PubMed ID: 15942088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASCT for AL: all's well that ends well.
    Wechalekar AD
    Blood; 2011 Oct; 118(16):4298-9. PubMed ID: 22021449
    [No Abstract]   [Full Text] [Related]  

  • 20. No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.
    Zeier M; Perz J; Linke RP; Donini U; Waldherr R; Andrassy K; Ho AD; Goldschmidt H
    Nephrol Dial Transplant; 2003 Dec; 18(12):2644-7. PubMed ID: 14605290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.